Concentrix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Concentrix (CNXC) is scheduled to report its Q2 earnings on June 26, with analysts forecasting EPS of $2.75, a slight increase from $2.69 year-over-year, and revenue of $2.38 billion, flat compared to the prior year. This follows the company's Q1 performance where it beat estimates, reporting EPS of $2.79 and revenue of $2.37 billion. CNXC shares closed up 0.2% at $54.17 on Wednesday, while recent analyst sentiment includes Canaccord Genuity maintaining a Buy rating with a reduced price target of $80, and Baird initiating coverage with an Outperform rating and a $70 target.

Analysis

Concentrix Corporation (CNXC) is approaching its second-quarter earnings report with expectations of modest year-over-year earnings per share (EPS) growth, but flat revenue. Analysts forecast Q2 EPS at $2.75, a slight increase from $2.69 in the prior year, while revenue is projected to be stagnant at $2.38 billion. This follows a first quarter where the company surpassed analyst estimates, delivering EPS of $2.79 against a $2.58 consensus, although revenue of $2.37 billion was slightly down from the previous year's $2.4 billion. This trend suggests a focus on profitability management amid a challenging top-line environment. Recent analyst actions reflect a cautiously optimistic outlook; while Canaccord Genuity reiterated a 'Buy' rating, it significantly reduced its price target from $100 to $80. Similarly, Baird initiated coverage with an 'Outperform' rating and a $70 price target. These targets, though lowered, still represent substantial upside from the stock's recent closing price of $54.17, indicating that the market may have priced in the current revenue headwinds.

Key Decisions for Investors

• Investors should closely watch the upcoming Q2 earnings report, as a beat on the modest $2.75 EPS and flat revenue expectations could serve as a significant positive catalyst given the stock's current valuation.
• Note that while analyst price targets of $70-$80 imply considerable upside, the recent 20% target reduction by Canaccord Genuity signals tempered long-term growth expectations that must be factored into risk assessments.
• Pay critical attention to management's forward-looking revenue guidance, as any sign of a return to top-line growth will be essential for the stock to re-rate towards current analyst targets.